Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Subcutaneous versus transvenous cardioverter defibrillator: improved outcomes in mid-term follow-up
Session:
Posters (Sessão 4 - Écran 4) - Taquicardia ventricular e morte súbita cardíaca
Speaker:
Joana Guimarães
Congress:
CPC 2023
Topic:
C. Arrhythmias and Device Therapy
Theme:
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
Subtheme:
08.7 Ventricular Arrhythmias and SCD - Other
Session Type:
Pósters Electrónicos
FP Number:
---
Authors:
Joana Guimarães; Diogo Fernandes; Gonçalo Costa; Eric Monteiro; Gustavo Campos; João Rosa; Ana Rita Gomes; Rafaela Fernandes; Vanessa Lopes; James Milner; Pedro Sousa; Graça Castro; Lino Gonçalves
Abstract
<p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong><span style="font-family:Arial,sans-serif">Background:</span></strong><span style="font-family:Arial,sans-serif"> Despite the importance of transvenous implantable cardioverter defibrillator (ICD) in sudden cardiac death prevention, they present a significant complication rate. </span></span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong><span style="font-family:Arial,sans-serif">Objectives:</span></strong><span style="font-family:Arial,sans-serif"> To compare mid-term outcomes following subcutaneous ICD (S-ICD) and transvenous ICD (TV-ICD) implantation.</span></span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong><span style="font-family:Arial,sans-serif">Methods:</span></strong><span style="font-family:Arial,sans-serif"> Observational, retrospective study of 164 patients submitted to ICD implantation in a single tertiary centre (41 S-ICD and 123 TV-ICD recipients). Primary endpoint <span style="color:black">was the composite of infection, procedural complications, lead-related complications and inappropriate shocks. </span></span></span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong><span style="font-family:Arial,sans-serif">Results: </span></strong><span style="font-family:Arial,sans-serif">S-ICD recipients were significantly younger (45 (IQR 23) vs 63 (IQR 17), p<.001), with higher <span style="color:black">left ventricular ejection fraction (55 (IQR 32) vs 34.5 (IQR 17), p=.001) and lower NYHA functional classes (p<.001). </span>During a median follow-up of 30 months, patients in the S-ICD group presented fewer device-related complications or inappropriate shocks than their TV-ICD counterparts (12.2% vs 24.8%, p=.048). This was driven by a reduction in lead-related complications (0% vs 7.3%, p=.08). There was no difference between both groups concerning the infection rate (2.4% vs 3.3%, p=.26), procedural complications (0% vs 1.6%, p=.41) and inappropriate shocks (10.3% vs 13.2%, p=.63). S-ICD required less re-interventions compared to TV-ICD (2.4% vs 9.2%, p=.05) and there was no difference regarding the rate of appropriate shocks (15.4% vs 9.9%, p=.35).</span> <span style="font-family:Arial,sans-serif">In multivariate analysis, S-ICD remained as the only independent predictor of lower complication rates (OR 0.22, 95% C.I. 0.053-0.922, p=.04).</span></span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong><span style="font-family:Arial,sans-serif">Conclusion: </span></strong><span style="font-family:Arial,sans-serif">Even after adjustment for potential confounders, S-ICD recipients presented a lower device complication rate and inappropriate shocks during mid-term follow-up and showed a trend towards less need for re-intervention. </span></span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site